REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,310,943 | +19.7% | 14,534 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $1,930,073 | -5.6% | 13,643 | +12.3% | 0.00% | -25.0% |
| Q1 2023 | $2,044,894 | -48.9% | 12,151 | -48.6% | 0.00% | -50.0% |
| Q4 2022 | $4,004,161 | -4.1% | 23,653 | +5.9% | 0.01% | -20.0% |
| Q3 2022 | $4,177,000 | +45.5% | 22,330 | +26.7% | 0.01% | +66.7% |
| Q2 2022 | $2,870,000 | -24.9% | 17,630 | -17.6% | 0.01% | -14.3% |
| Q1 2022 | $3,821,000 | -33.6% | 21,405 | -1.6% | 0.01% | -36.4% |
| Q4 2021 | $5,753,000 | -14.9% | 21,756 | -7.2% | 0.01% | -21.4% |
| Q3 2021 | $6,759,000 | +255.5% | 23,432 | +146.0% | 0.01% | +250.0% |
| Q2 2021 | $1,901,000 | -38.7% | 9,527 | -40.3% | 0.00% | -42.9% |
| Q1 2021 | $3,100,000 | -32.2% | 15,946 | -33.2% | 0.01% | -41.7% |
| Q4 2020 | $4,572,000 | +112.8% | 23,856 | +63.0% | 0.01% | +100.0% |
| Q3 2020 | $2,149,000 | -7.6% | 14,640 | -22.2% | 0.01% | -25.0% |
| Q2 2020 | $2,325,000 | +50.6% | 18,813 | -29.5% | 0.01% | +33.3% |
| Q1 2020 | $1,544,000 | – | 26,688 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |